Delayed initiation of DS-5272 (from day 11 to day 21) still prolonged the survival of MLL-AF9 leukemia mice, with reduction of GFP+ leukemia cells in peripheral blood and improvement of hind limb paralysis of leukemic mice (Fig. 2d and Supplementary Movie 1-4). This evidence concerns the gene KMT2A and leukemia.